FBInvestor
Stocks / 4d Molecular Therapeutics In
Institutional Ownership

4d Molecular Therapeutics In

CUSIP 35104E100COMFDMTQ1 2026

No Form 4 insider transactions ingested yet

Insider (Form 4) filings for 4d Molecular Therapeutics In are fetched from SEC EDGAR on a rolling basis. Check back shortly.